Dare Bioscience (DARE) Operating Leases (2019 - 2026)
Dare Bioscience's (DARE) quarterly Operating Leases came in at $559365.0 in Q4 2025, down 25.85% YoY from $754383.0 in Q4 2024, and down 37.71% on a QoQ basis from $898000.0 in Q3 2025.
Dare Bioscience (DARE) Operating Leases (2019 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 7 years of Operating Leases data on file, last reported at $559365.0 in Q4 2025.
- Quarterly Operating Leases fell 25.85% year-over-year to $559365.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $559365.0 (down 25.85% YoY) and the FY2025 annual result came in at $559365.0, down 25.85% from the prior year.
- Operating Leases fell to $559365.0 in Q4 2025, from $898000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $1.6 million in Q1 2024 to a low of $15799.0 in Q3 2021.
- A 5-year average of $684512.9 and a median of $678839.0 in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases slumped 98.0% — and 2024, when it jumped 6530.43%.
- Tracing DARE's Operating Leases over 5 years: stood at $15799.0 in 2021, then surged by 471.85% to $90346.0 in 2022, then jumped by 935.73% to $935743.0 in 2023, then declined by 19.38% to $754383.0 in 2024, then retreated by 25.85% to $559365.0 in 2025.
- The last three Operating Leases figures came in at $559365.0 (Q4 2025), $898000.0 (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - |
| 10 | Dare Bioscience | 12.45 Mn | -166,716.50 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 868,366.00 |
| Dec 31, 2025 | 559,365.00 |
| Sep 30, 2025 | 898,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 603,295.00 |
| Dec 31, 2024 | 754,383.00 |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 935,743.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 90,346.00 |
| Sep 30, 2022 | 195,000.00 |
| Jun 30, 2022 | 1.15 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Sep 30, 2021 | 15,799.00 |
| Jun 30, 2021 | 73,516.00 |
| Mar 31, 2021 | 151,786.00 |
| Dec 31, 2020 | 41,844.00 |